Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 386,750 | 796,083 | 860,500 | 890,250 | 874,610 | 3,808,193 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 415,076,707 | 412,894,240 | 422,094,519 | 452,689,157 | 412,031,487 | 2,114,786,110 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 6,235,464 | 7,848,069 | 7,186,368 | 6,886,071 | 5,549,236 | 33,705,208 |
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | 421,698,921 | 421,538,392 | 430,141,387 | 460,465,478 | 418,455,333 | 2,152,299,511 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | 2,152,299,511 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 421,698,921 | 421,538,392 | 430,141,387 | 460,465,478 | 418,455,333 | 2,152,299,511 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 1,877,063 | 827,999 | 1,924,522 | 1,827,599 | 553,522 | 7,010,705 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | 1,877,063 | 827,999 | 1,924,522 | 1,827,599 | 553,522 | 7,010,705 |
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 423,575,984 | 422,366,391 | 432,065,909 | 462,293,077 | 419,008,855 | 2,159,310,216 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2020 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2020 |
(iii) Distributable Amount for 2020 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2020 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2020: | ||||
| a From 2015....... | ||||
| b From 2016....... | ||||
| c From 2017....... | ||||
| d From 2018....... | ||||
| e From 2019....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2020 distributable amount | ||||
|
i
Carryover from 2015 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2020 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2020 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2020, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2020. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2021. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2016..... | ||||
| b Excess from 2017..... | ||||
| c Excess from 2018..... | ||||
| d Excess from 2019..... | ||||
| e Excess from 2020..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990 - ORGANIZATION'S MISSION | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") IS DEDICATED TO PROVIDING QUALITY ALLOGRAFT TISSUE FOR TRANSPLANTATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY, AND CARE FOR RECIPIENTS, DONORS AND THEIR FAMILIES. MTF CONTINUES TO PROMOTE THE HEALTH AND WELFARE OF THE GENERAL PUBLIC BY (1) MAXIMIZING THE AVAILABILITY OF HIGH QUALITY HUMAN TISSUE INCLUDING BONE, DERMAL AND BIRTH TISSUE; 2) SUPPORTING MEDICAL, SCIENTIFIC AND OTHER EDUCATIONAL RESEARCH WITH RESPECT TO TISSUE DONATION, RECOVERY AND TRANSPLANTATION; AND(3) EDUCATING THE GENERAL PUBLIC WITH RESPECT TO THE IMPORTANCE AND BENEFITS OF TISSUE DONATION AND TRANSPLANTATION. THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. WAS INCORPORATED ON JANUARY 30, 1987, AS A DISTRICT OF COLUMBIA NON- PROFIT MEMBERSHIP ORGANIZATION AND IS A 501(C)(3)ORGANIZATION. THERE IS A CRITICAL NEED FOR MUSCULOSKELETAL, CARDIOVASCULAR, SKIN, BIRTH AND OCULAR TISSUE FOR TRANSPLANTATION. IN ORDER TO ACCOMPLISH MTF'S MISSION AND THESE ACTIVITIES, THE FOUNDATION MAINTAINS A DONOR RECOVERY NETWORK, SUPPORTS DONOR AWARENESS PROGRAMS FOR THE PUBLIC, DONATES BONE AND OTHER TISSUE FOR RESEARCH, PROVIDES RESEARCH GRANTS, AND OTHERWISE SUPPORTS BONE, SKIN, WOUND CARE AND CARDIOVASCULAR TISSUE TRANSPLANTATION, RESEARCH AND EDUCATIONAL PROGRAMS. THE FOUNDATION'S MEMBERSHIP IS COMPRISED OF 501(C)(3) NON-PROFIT ORGANIZATIONS. THE MEMBERSHIP CONSISTS OF FORTY-SEVEN ACADEMIC MEMBERS (ORTHOPEDIC TEACHING INSTITUTIONS), THIRTY-ONE RECOVERY ORGANIZATIONS (ORGAN, EYE AND TISSUE PROCUREMENT ORGANIZATIONS) THROUGHOUT THE UNITED STATES. BIOCON, INC., A NON-PROFIT 501(C)(3) ORGANIZATION, SERVES AS THE SOLE CORPORATE MEMBER OF THE FOUNDATION. THE FOUNDATION MAINTAINS A NATIONWIDE DONOR RECOVERY NETWORK THAT IS BASED ON ITS AFFILIATION WITH ITS RECOVERY AND REFERRING MEMBERS. THIS NATIONAL NETWORK ALLOWS THE PUBLIC TO QUICKLY ACCESS NEEDED ALLOGRAFT TISSUE. BONE AND OTHER ALLOGRAFT TISSUE RECOVERED THROUGH THIS NETWORK IS SUBJECT TO STANDARDIZED SCREENING CRITERIA FOR DONATION ESTABLISHED BY THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND DONATION BOARD OF TRUSTEES (DESCRIBED BELOW). THE FOUNDATION ALSO MAINTAINS A QUALITY ASSURANCE PROGRAM WITH RESPECT TO ALLOGRAFT TISSUES RECOVERED THROUGH THE NETWORK. THIS QUALITY PROGRAM IS BASED ON THE POLICIES ADOPTED BY THE AMERICAN ASSOCIATION OF TISSUE BANKS AND THE REGULATIONS PUBLISHED BY THE FOOD & DRUG ADMINISTRATION AND OTHER REGULATORY AGENCIES OUTSIDE THE U.S WHERE THE FOUNDATION DISTRIBUTES TISSUE. THE FOUNDATION PROVIDES RECOVERY ORGANIZATION MEMBERS AND THE GENERAL COMMUNITY THEY SERVE WITH FUNDING FOR HOSPITAL DEVELOPMENT AND DONOR AWARENESS SERVICES. THESE SERVICES ALSO INCLUDE PROVIDING TRAINING TO RECOVERY ORGANIZATION MEMBERS, EDUCATIONAL SYMPOSIUMS TO BOTH RECOVERY ORGANIZATION MEMBERS AND HOSPITAL STAFF, AND EDUCATIONAL MATERIALS FOR USE IN SEMINARS TO HOSPITAL PROFESSIONALS AND THE GENERAL PUBLIC. AS INDICATED IN ARTICLE III OF THE FOUNDATION'S BYLAWS, A MEMBER OF THE FOUNDATION CAN BE AN ACADEMIC MEDICAL INSTITUTION WITH AN ACCREDITED RESIDENCY TRAINING PROGRAM; A FEDERALLY CHARTERED OPO; OR AN EYE/TISSUE BANK. ALL MEMBERS AGREE TO SUPPORT THE FOUNDATION'S MISSION EITHER THROUGH A SERVICES AND SUPPLY AGREEMENT OR SERVICES AND RECOVERY AGREEMENT. SOME MEMBERS ARE ELIGIBLE FOR RESEARCH FUNDING (SEE SCHEDULE I, PT. IV FOR GRANT PROGRAM OVERVIEW) FROM THE FOUNDATION UPON RECOMMENDATION AND/OR APPROVAL OF EITHER THE BOARD OF DIRECTORS OR THE MEDICAL BOARD OF TRUSTEES. ALTHOUGH ALL OF THE FOUNDATION'S MEMBERS ARE NON-PROFIT 501(C)(3) ORGANIZATIONS, THE FOUNDATION MAKES ITS TRANSPLANTATION TISSUE NETWORK AND PROGRAMS AVAILABLE TO ANY PERSON OR ORGANIZATION (TYPICALLY THROUGH THEIR HOSPITALS AND PHYSICIANS)IN NEED OF ALLOGRAFT TISSUE. THE FOUNDATION FUNDS ALL COSTS ASSOCIATED WITH THE RECOVERY OF DONOR TISSUES. IT SUPPORTS THESE COSTS WITH FEES INTENDED TO COVER ITS EXPENSES (INCLUDING FUNDING FOR RESEARCH) FROM THE USER OF THE TISSUE. THE FOUNDATION WILL MAKE SUCH TISSUE AVAILABLE AT A REDUCED FEE OR NO CHARGE FOR VARIOUS CAUSES INCLUDING TRANSPLANTATION AND FOR PURPOSES OF RESEARCH BY 501(C)(3) ORGANIZATIONS. ALL FUNDS REALIZED BY THE FOUNDATION ARE USED TO COVER THE COSTS OF ITS PROGRAM ACTIVITIES (INCLUDING OVERHEAD)WITH ANY SURPLUS APPLIED TOWARDS SUBSIDIZING THE COSTS OF THOSE IN NEED OF TISSUE WHO ARE UNABLE TO AFFORD IT, TO FUND EDUCATION AND RESEARCH, TO MAINTAIN THE APPROPRIATE INFRASTRUCTURE AND/OR TO BUILD UP RESERVES NEEDED TO MAINTAIN AND EXPAND THE FOUNDATION'S PROGRAMS. WHILE THE FOUNDATION'S ACTIVITIES ARE MONITORED BY ITS MEMBERS, THE FOUNDATION HAS AN ELEVEN PERSON BOARD OF DIRECTORS AND TWO NON-VOTING EMERITUS MEMBERS. THIS BOARD IS COMPRISED PRIMARILY OF WORLD RENOWN EXPERTS FROM THE NON-PROFIT HEALTHCARE COMMUNITY HAVING VARIOUS SCIENTIFIC, TRANSPLANT, AND MEDICAL SPECIALTIES. THE BOARD OF DIRECTORS HAS ULTIMATE RESPONSIBILITY TO MANAGE THE FOUNDATION. OF THE BOARD'S 11 VOTING MEMBERS, THERE ARE TWO MEMBERS EACH FROM THE MEDICAL BOARD AND THE DONATION BOARD OF TRUSTEES. SERVING IN TANDEM WITH OTHER BOARD OF DIRECTORS, THE FOUNDATION HAS A MEDICAL BOARD OF TRUSTEES (THE "MEDICAL BOARD") AND A DONATION BOARD OF TRUSTEES ("DONATION BOARD"). THE MEDICAL BOARD IS COMPRISED OF RESPECTIVE PHYSICIANS FROM ORTHOPEDIC AND PLASTIC SURGERY DEPARTMENTS OF THE ACADEMIC INSTITUTION MEMBERS OF THE FOUNDATION, PLUS ADDITIONAL PERSONS WHO HAVE SPECIFIC EXPERTISE PERTAINING TO TRANSPLANTATION ETHICS AND RESEARCH ACTIVITIES WITHIN THE INDUSTRY. WHILE THE SPECIFIC POWERS AND RESPONSIBILITIES OF THE MEDICAL BOARD ARE DETAILED IN ARTICLE IV, SECTION 2 OF THE FOUNDATION'S BYLAWS, IN GENERAL IT PROVIDES THAT THE MEDICAL BOARD SHALL ADVISE THE FOUNDATION WITH RESPECT TO OPTIMIZING THE DISTRIBUTION OF RESEARCH GRANTS, THE CHOICE OF AREAS MERITING RESEARCH FUNDING, AND ESTABLISHING THE STANDARD POLICIES AND PROTOCOLS RELATING TO THE SCREENING, RECOVERY, TRANSPORT, TESTING, PROCESSING, STORAGE AND DISTRIBUTION OF TRANSPLANTABLE BONE AND TISSUE. THE DONATION BOARD IS COMPRISED OF INDIVIDUALS KNOWLEDGEABLE IN THE FIELD OF TISSUE DONATION AND RECOVERY AND ARE LEADERS OF THE FOUNDATION'S RECOVERY ORGANIZATION MEMBERSHIP. WHILE THE SPECIFIC POWERS AND RESPONSIBILITIES OF THE DONATION BOARD ARE DETAILED IN ARTICLE VI, SECTION 2 OF THE FOUNDATION'S BYLAWS, IN GENERAL THE DONATION BOARD PROVIDES THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT OF THE FOUNDATION WITH RECOMMENDATIONS WITH REGARD TO TISSUE DONATION PRACTICES SUCH AS SCREENING, RECOVERY, AND TESTING CRITERIA. THE FOUNDATION SUPPORTS EDUCATIONAL, SCIENTIFIC AND RESEARCH PROJECTS BY DISTRIBUTING FUNDS AND MAKING AVAILABLE, AT NO CHARGE, DONATED TISSUE FOR RESEARCH. THE FOUNDATION FUNDS MANY TYPES OF PROJECTS RELATED TO ADVANCING TRANSPLANT SCIENCE. ACCORDINGLY, GRANTS ARE PROVIDED FOR PROJECTS IN TISSUE DONATION AND APPLICATION. IN SUM, ALL OF THE ACTIVITIES OF THE FOUNDATION HAVE BEEN AND WILL BE DIRECTED AT MEETING THE NEEDS OF THE GENERAL PUBLIC FOR ALLOGRAFT TISSUE AND/OR IMPROVING THE MANNER IN WHICH TRANSPLANT TISSUE IS MADE AVAILABLE TO THE GENERAL PUBLIC. ADDITIONALLY, THE FOUNDATION SUPPORTS RESEARCH TO ADVANCE THE SCIENCE OF MUSCULOSKELETAL AND OTHER TISSUE APPLICATIONS. THE FOUNDATION OFFERS EDUCATIONAL SERVICE TO SURGEONS AND NURSES BY WAY OF CONTINUING MEDICAL EDUCATION (CME) AND CONTACT HOUR PROGRAMS. IN ADDITION, THE FOUNDATION PROVIDES EDUCATION THROUGH A SPEAKER PROGRAM IN CONJUNCTION WITH ORTHOPEDIC TEACHING HOSPITALS ACROSS THE UNITED STATES. SURGEONS UTILIZE THE FOUNDATION'S ALLOGRAFT FORMS DURING PROCEDURAL TRAINING OR CADAVERIC SPECIMENS DURING CME COURSES. FINALLY, THE FOUNDATION OFFERS GRANTS TO ITS RECOVERY PARTNERS TO EDUCATE THE PUBLIC AND HEALTHCARE PROFESSIONAL INVOLVED IN THE DONATION PROCESS. |
| FORM 990, PAGE 1, PART I, LINE 6 | COMPASSIONATE CARE FOR DONOR FAMILIES IS AT THE HEART OF OUR MISSION AT MTF THE DONOR FAMILY SUPPORT SERVICES VOLUNTEERS NEVER FORGETS THE MAGNITUDE OF THE GIFT OUR DONORS AND THEIR FAMILIES MAKE. WE'VE SET THIS SITE UP JUST FOR YOU, A PLACE YOU CAN COME TO LEARN ABOUT TISSUE DONATION, FIND HELPFUL RESOURCES AND MORE. WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS-COMMUNITY/DONORS-FAMILIES OUR VOLUNTEERS ARE THERE TO HELP YOU COPE WITH YOUR LOSS, WHILE APPRECIATING THE INCREDIBLE GIFT YOUR LOVED ONE HAS MADE TO OTHERS INCLUDING PERIODIC PERSONAL PHONE CALLS, REMEMBRANCES INCLUDING SYMPATHY CARDS, FREE INFORMATIVE PACKET WITH BEREAVEMENT SUPPORT LITERATURE, SUPPORT GROUP INFORMATION AND MORE. MTF VOLUNTEER GROUPS COMPRISED OF DONOR FAMILY MEMBERS AND BIRTH TISSUE DONORS WHO SHARE THEIR STORIES AND ENCOURAGE OTHERS TO CONSIDER DONATION. MANY FAMILIES HAVE FOUND THAT BEING INVOLVED WITH OTHER DONOR FAMILIES HAS A PROFOUND EFFECT ON THEIR LIVES AND APPRECIATE THE OPPORTUNITY TO SHARE THE STORY OF THEIR LOVED ONES. TISSUE RECIPIENTS HAVE INSPIRATIONAL STORIES OF HOW A TRANSPLANT TRANSFORMED THEIR LIVES. OUR VOLUNTEERS ARE LOCATED THROUGHOUT THE COUNTRY. WE CAN PROVIDE YOU WITH INFORMATION ON HOW YOU CAN GET INVOLVED AND VOLUNTEER BY CONTACTING VOLUNTEERS@MTF.ORG. THE LINKING LIVES PROGRAM IS A VOLUNTARY PROGRAM THAT GIVES TISSUE RECIPIENTS THE OPPORTUNITY TO WRITE A LETTER OF THANKS TO THEIR DONOR FAMILY. RECIPIENTS ARE ENCOURAGED TO WRITE A LETTER WHICH MTF WILL FORWARD TO THE AGENCY THAT COORDINATED THE TISSUE RECOVERY. WE PROVIDE TISSUE RECIPIENTS WITH GUIDELINES FOR WRITING TO THEIR DONOR FAMILY. THE RECOVERY AGENCY SENDS THE LETTER TO THE DONOR FAMILY. DONOR FAMILIES MAY NOT HEAR FROM THEIR TISSUE RECIPIENTS AS MANY PATIENTS ARE UNAWARE THAT THEY CAN WRITE TO THEIR DONOR FAMILIES. HOWEVER, THOSE WHO DO RECEIVE A LETTER FROM A GRATEFUL TISSUE RECIPIENT HAVE SHARED HOW IMPORTANT THOSE LETTERS CAN BE. |
| FORM 990, PAGE 2, PART III, LINE 4A | MTF PROVIDES ALLOGRAFT TISSUES TO THE MEDICAL COMMUNITY. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 150,000 DONORS. IN 2020, MTF RECOVERED TISSUE FROM OVER 5,500 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 6,300 DONORS FOR USE IN BURN, GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 1,100 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 683 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED APPROXIMATELY 400,000 UNITS OF ALLOGRAFT TISSUE DURING 2020. IN ADDITION TO THE FURTHERANCE OF THE MISSION DRIVEN RESULTS IN 2019 (HIGHLIGHTED BELOW) AND GIVEN THE CHALLENGES FACED IN 2020, MTF CONTINUES TO DEVELOP INNOVATIVE TISSUE FORMS, FOCUSED ON SOLVING REAL-WORLD, CLINICAL PROBLEMS. MTF HAS ALSO CONTINUED ITS EFFORTS TO PROVIDE SPECIAL RESEARCH TISSUE FOR RESEARCH PERFORMED BY MEMBERS OF THE ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE, AN ORGANIZATION DEDICATED TO DEVELOPING MEDICAL THERAPIES FOR WOUNDED SOLDIERS. MTF CONTINUED TO MAKE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS. IN THE ORTHOPEDICS FRANCHISE, MTF DEVELOPED NEW PARTNERSHIPS, FURTHER ENHANCING ITS OUTREACH, DISTRIBUTION NETWORK, AND ABILITY TO BRING DONATED ALLOGRAFT TISSUES TO PATIENT RECIPIENTS. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY FRANCHISE, MTF DEVELOPED STRATEGIC INTER-INDUSTRY PARTNERSHIPS TO UTILIZE CROSS- ORGANIZATIONAL EXPERTISE, GREATLY EXPANDING DONATION NETWORKS AND INCREASING PROCESSING CAPACITY, AND THEREFORE THE AVAILABILITY OF HUMAN DERMAL AND SPLIT-THICKNESS ALLOGRAFTS. MTF'S WOUND CARE DIVISION WAS ABLE TO EXPAND THE DISTRIBUTION OF ITS WOUND CARE PORTFOLIO TO MORE RECIPIENTS IN THE VA AND PUBLIC HOSPITALS IN 2020. MTF CONTINUED ITS CLINICAL STUDY PORTFOLIO, INCREASING ITS COMPENDIUM OF CLINICAL DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES. IN ADDITION TO RETAINING PERSONNEL AND CAREFULLY MONITORING AND ADAPTING TO SUPPLY CHAIN CHALLENGES, MTF WAS ALSO ABLE TO DONATE PERSONAL PROTECTIVE EQUIPMENT (PPE) TO LOCAL HEALTHCARE FACILITIES IN NEED DURING THE PANDEMIC. MTF CONTINUES INTO 2021 DEVELOPING NOVEL TISSUE FORMS AND PROCESSING METHODS TO SOLVE CLINICAL PROBLEMS. MTF IS FOCUSED ON HONORING THE DONATED GIFT OF HUMAN TISSUE, ENSURING QUALITY TISSUE FORMS, MAXIMIZING THE DONOR GIFT, AND WORKING WITH SURGEONS TO SAVE AND HEAL LIVES. ___________________________________________________________________________ IN 2019, MTF CONTINUED TO INCREASE TISSUE UTILIZATION AND PLACEMENT OF TISSUE FORMS IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS. IN THE ORTHOPEDICS MARKET, MTF LAUNCHED QUICKGRAFT, A PRE-SUTURED TENDON. THIS TECHNOLOGY ALLOWS MTF AND SURGEON PARTNERS TO HONOR THE DONATED GIFT BY INCREASING THE PREDICTABILITY OF SURGICAL PROCEDURES FOR THE PATIENT. MTF ALSO CONTINUED TO INCREASE ITS UTILITY OF THE MOPS OSTEOCHONDRAL PRESERVATION TECHNOLOGY. THIS TECHNOLOGY FURTHER HONORS THE GIFT BY EXTENDING THE STORAGE LIFE OF DONATED TISSUE. IN 2019 MTF BEGAN TO DISTRIBUTE CC+, A CORTICAL-CANCELLOUS BONE VOID FILLER. FURTHERMORE, MTF LAUNCHED A NEW CORTICAL FIBER BASED BONE VOID FILLER, FIBER FUSE, WHICH POSSESSES OSTEO-INDUCTIVE, OSTEO-CONDUCTIVE POTENTIAL AND EXCELLENT HANDLING PROPERTIES. IN PLASTIC AND RECONSTRUCTIVE SURGERY (PRS), MTF LAUNCHED FLEXHD PRE, AN INNOVATIVE TISSUE FORM, DESIGNED TO ALLOW SURGEONS GREATER OPTIONS FOR BREAST RECONSTRUCTION PROCEDURES FOLLOWING MASTECTOMY. THE MTF PRS DIVISION ALSO SAW AN INCREASED USE OF RENUVA, AN ADIPOSE MATRIX, FOR USES SUCH AS RECONSTRUCTION AND TREATMENT OF SMALL VOLUME DEFECTS WHERE HOST FAT HAS EITHER DECREASED OR BEEN DEGRADED OR LOST DUE TO TRAUMA OR DISEASE. MTF'S WOUND CARE DIVISION DEVELOPED AND LAUNCHED SOMAGEN, AN ACELLULAR DERMAL ALLOGRAFT AND LENEVA A SOFT TISSUE ADIPOSE MATRIX. MTF ALSO CONTINUED EXPANDING THE DISTRIBUTION OF ITS WOUND CARE PORTFOLIO TO MORE RECIPIENTS IN THE VA AND PUBLIC HOSPITALS THROUGHOUT THE YEAR. MTF CONTINUED TO EXPAND ITS CLINICAL STUDY PORTFOLIO, INCREASING ITS COMPENDIUM OF CLINICAL DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND BREAST RECONSTRUCTION. MTF CONTINUED ITS PROSPECTIVE RANDOMIZED CLINICAL TRIAL FOR FLEXHD PLIABLE ACELLULAR DERMAL MATRIX FOR USES SUCH AS BREAST RECONSTRUCTION FOLLOWING MASTECTOMY. IN THE WOUND CARE MARKET, CLINICAL STUDIES AND RESEARCH DATA HAVE PROVIDED THE INFORMATION FOR MTF TO ATTAIN COVERAGE FOR APPROXIMATELY 73% OF ALL COVERED AMERICAN LIVES IN 2019. MTF CONTINUED ITS SUPPORT OF THE AMERICAN SOCIETY OF PLASTIC SURGEONS (ASPS) AND THE PLASTIC SURGERY FOUNDATION (PSF) WHICH PROVIDES OPPORTUNITIES FOR SURGEONS TO PERFORM ALLOGRAFT BASED RESEARCH TO ADVANCE THE SCIENCE OF ALLOGRAFT USE IN PLASTIC/RECONSTRUCTIVE PROCEDURES. MTF ALSO REMAINS COMMITTED TO SUPPORTING BREAST RECONSTRUCTION AWARENESS (BRA) DAY EACH YEAR AND INCLUDES EDUCATION FOR BOTH PATIENTS AND SURGEONS ON THE OPTIONS AVAILABLE TODAY FOR WOMEN, HELPING TO ENSURE SURVIVORS' RIGHTS TO MAKE AN INFORMED DECISION. MTF ALSO CONTINUED ITS FINANCIAL PLEDGE OF (1M OVER FIVE YEARS) TO SUPPORT BIOLOGIC RESEARCH THROUGH THE PLASTIC SURGERY FOUNDATION (PSF). MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS. |
| FORM 990, PART V, LINE 4B | CANADA |
| FORM 990, PAGE 6, PART VI, LINE 6 | MTF IS ORGANIZED WITH TWO CLASSES OF MEMBERSHIP WHICH ARE (1) NON- CORPORATE MEMBERSHIP AND (2) CORPORATE MEMBERSHIP. THE NON-CORPORATE MEMBERS INCLUDE ACADEMIC MEMBERS, RECOVERY MEMBERS AND RESEARCH MEMBERS. THE SOLE CORPORATE MEMBER OF MTF IS BIOCON, INC. |
| FORM 990, PAGE 6, PART VI, LINE 7A | THE SOLE CORPORATE MEMBER MAY APPOINT ALL DIRECTORS SUBJECT TO THE FOLLOWING: THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "MEDICAL BOARD OF TRUSTEES" WILL BE APPOINTED TO THE BOARD. ALSO, THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "DONATION BOARD OF TRUSTEES" WILL BE APPOINTED MEMBERS OF THE BOARD OF DIRECTORS. |
| FORM 990, PAGE 6, PART VI, LINE 7B | ANY CHANGES THAT ARE A MATERIAL CHANGE TO THE GOVERNING DOCUMENTS OF THE FOUNDATION (EX.BY-LAWS OR ARTICLES OF INCORPORATION) MUST BE APPROVED BY THE MEMBERS OF THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND THE DONATION BOARD OF TRUSTEES. FINAL APPROVAL OF THESE CHANGES MUST BE APPROVED BY THE BOARD OF DIRECTORS. |
| FORM 990, PAGE 6, PART VI, LINE 11B | MEMBERS OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS WERE PROVIDED WITH A COPY OF FORM 990. THE 990 WAS REVIEWED AT AN OPEN MEETING OF THE AUDIT COMMITTEE. SUBSEQUENT TO MODIFICATIONS, IF ANY, AS A RESULT OF THE AUDIT COMMITTEE MEETING, THE FORM 990 IS THEN CIRCULATED TO ALL MEMBERS OF THE BOARD OF DIRECTORS FOR THEIR FINAL REVIEW AND APPROVAL BEFORE FILING. |
| FORM 990, PAGE 6, PART VI, LINE 12C | MTF SENDS A COMPREHENSIVE QUESTIONNAIRE ANNUALLY TO BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES REQUESTING DISCLOSURE OF ANY CONFLICTS OF INTEREST. MTF IS DILIGENT IN REVIEWING THE ANNUAL DISCLOSURE FORMS SUBMITTED BY THE COVERED PERSONS, AND IN SCREENING, COMPILING AND MAINTAINING THE SUBMISSIONS. |
| FORM 990, PAGE 6, PART VI, LINE 15A | EXECUTIVE COMPENSATION REVIEW: EACH YEAR, MTF REVIEWS AND ASSESSES THE REASONABLENESS OF TOTAL COMPENSATION ARRANGEMENTS FOR OUR EXECUTIVE TEAM, INCLUDING THE CEO. THE ANALYSIS INCORPORATES COMPENSATION SURVEY DATA, LAST COMPILED IN SEPTEMBER 2020, FORM 990'S OF COMPANIES OF RELATED INDUSTRIES AND SIMILAR SIZE. A BLEND OF BOTH FOR-PROFIT AND NOT-FOR-PROFIT COMPANIES IS USED. EVERY THIRD YEAR (MOST RECENTLY SEPTEMBER 2020), MTF RETAINS THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTANT TO ASCERTAIN AND DETERMINE THAT MTF IS PAYING AND PROVIDING A REASONABLE TOTAL COMPENSATION PACKAGE TO THEIR EXECUTIVES AND TO PROVIDE AN OPINION LETTER OF THEIR FINDINGS. COMPENSATION COMMITTEE REVIEW MTF'S BOARD OF DIRECTORS ESTABLISHED A COMPENSATION COMMITTEE IN 1995. THE RESPONSIBILITY OF THE COMMITTEE INCLUDES THE REVIEW AND APPROVAL OF EXECUTIVE AND STAFF COMPENSATION AND BENEFITS. THE COMPENSATION COMMITTEE TYPICALLY MEETS SEMI-ANNUALLY TO REVIEW MERIT AND BONUS RECOMMENDATIONS. A COPY OF THE COMPENSATION COMMITTEE'S CHARTER, AGENDAS, MEETING MATERIALS, AND MEETING MINUTES ARE MAINTAINED. |
| FORM 990, PAGE 6, PART VI, LINE 15B | THE PROCESS IS THE SAME AS DESCRIBED ABOVE IN LINE 15A. |
| FORM 990, PAGE 6, PART VI, LINE 19 | MTF MAKES ITS FORM 990 AND OTHER PUBLIC DOCUMENTS AVAILABLE TO THE PUBLIC AT ITS REGULAR PLACE OF BUSINESS IN PERSON, REQUESTS THROUGH EMAIL OR VIA US POSTAL SERVICE. IN ADDITION FORM 990 IS AVAILABLE ON THE INTERNET AT WWW.GUIDESTAR.ORG. |
| FORM 990, PART XI, LINE 9 | UNREALIZED FOREIGN EXCHANGE 675,161 ACCRUED GRANTS -852,403 BOOK / TAX DEPRECIATION DIFFERENCE 7,583,333 TOTAL 7,406,091 |
| Software ID: | |
| Software Version: |